Acute Cholangitis clinical trials

Explore recruiting acute cholangitis clinical trials.

Recruiting acute cholangitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Cholangitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Double blind, multicentric, randomized, placebo-controlled trial, evaluating the efficacy of 24-month of bezafibrate in primary sclerosing cholangitis with persistent cholestasis despite ursodeoxycholic acid therapy (BEZASCLER)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Fecal microbiota transplantation for primary sclerosing cholangitis - randomized study versus sham transplantation (FMT-SCLER).

France

Phase II and Phase III (Integrated) EU CTIS Study details

Acute Cholangitis trials by city

Acute Cholangitis in Toronto Acute Cholangitis in Vancouver Acute Cholangitis in Montreal Acute Cholangitis in Calgary Acute Cholangitis in Edmonton Acute Cholangitis in Ottawa Acute Cholangitis in Winnipeg Acute Cholangitis in Quebec City Acute Cholangitis in Hamilton Acute Cholangitis in Kitchener Acute Cholangitis in London Acute Cholangitis in Halifax Acute Cholangitis in New York Acute Cholangitis in Los Angeles Acute Cholangitis in Chicago Acute Cholangitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease